Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve brain health outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. was founded in 2006 and is based in Kenmore, New York.
Metrics to compare | AIFF | Sector Sector - Average of metrics from a broad group of related Technology sector companies | Relationship RelationshipAIFFPeersSector | |
---|---|---|---|---|
P/E Ratio | −1.5x | −1.2x | −0.7x | |
PEG Ratio | 0.00 | −0.01 | 0.00 | |
Price/Book | 3.4x | 0.5x | 2.6x | |
Price / LTM Sales | 95.5x | 1.4x | 3.4x | |
Upside (Analyst Target) | - | 39.3% | 36.2% | |
Fair Value Upside | Unlock | 18.2% | 4.1% | Unlock |